ZVRA (STOCKS)
Zevra Therapeutics, Inc. Common Stock
$11.290000
-0.150000 (-1.31%)
Prev close: $11.440000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Neil F. McFarlane
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $754.65M
- Employees
- 59
- P/E (TTM)
- 12.34
- P/B (TTM)
- 3.12
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
9
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$0.14 | $0.11 | +0.0305 | +27.85% |
|
Mar 2026 (Q1)
|
$0.18 | $0.08 | +0.0976 | +118.45% |
|
Dec 2025 (Q4)
|
$0.21 | $0.05 | +0.1590 | +311.76% |
|
Sep 2025 (Q3)
|
$-0.01 | $-0.04 | +0.0257 | +71.99% |
Financial Statements
| Revenues | $136.07M |
| Benefits Costs and Expenses | $66.78M |
| Costs And Expenses | $89.56M |
| Nonoperating Income/Loss | -$13.09M |
| Operating Expenses | $53.69M |
| Selling, General, and Administrative Expenses | $74.63M |
| Operating Income/Loss | $82.38M |
| Income/Loss From Continuing Operations After Tax | $58.26M |
| Income/Loss From Continuing Operations Before Tax | $69.29M |
| Income Tax Expense/Benefit | $11.03M |
| Net Income/Loss | $58.26M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $58.26M |
| Net Income/Loss Available To Common Stockholders, Basic | $56.00M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $2.26M |
| Preferred Stock Dividends And Other Adjustments | $2.26M |
| Basic Earnings Per Share | $0.95 |
| Diluted Earnings Per Share | $0.92 |
| Basic Average Shares | 115,096,431 |
| Diluted Average Shares | 117,217,149 |
| Assets | $302.71M |
| Current Assets | $251.30M |
| Inventory | $2.45M |
| Other Current Assets | $248.85M |
| Noncurrent Assets | $51.41M |
| Fixed Assets | $641.00K |
| Intangible Assets | $5.79M |
| Other Non-current Assets | $44.98M |
| Liabilities | $85.06M |
| Current Liabilities | $48.63M |
| Noncurrent Liabilities | $36.43M |
| Equity | $217.65M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $217.65M |
| Liabilities And Equity | $302.71M |
| Net Cash Flow From Operating Activities | $33.40M |
| Net Cash Flow From Operating Activities, Continuing | $33.40M |
| Net Cash Flow From Investing Activities | $106.72M |
| Net Cash Flow From Investing Activities, Continuing | $106.72M |
| Net Cash Flow From Financing Activities | -$42.14M |
| Net Cash Flow From Financing Activities, Continuing | -$42.14M |
| Net Cash Flow | $97.98M |
| Net Cash Flow, Continuing | $97.98M |
| Comprehensive Income/Loss | $58.47M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $58.47M |
| Other Comprehensive Income/Loss | $58.47M |
| Other Comprehensive Income/Loss Attributable To Parent | $211.00K |